The EveryLife Foundation for Rare Diseases kicks off its 15th Annual Rare Disease Week on Capitol Hill from February 24-26, 2026, uniting advocates from across the nation. This isn't just another annual gathering; it's an arena where patients, caregivers, and policymakers converge to amplify the voices of millions living with rare conditions. The stakes are high—improving lives hinges on effective advocacy and informed policymaking.
Connecting Communities: Changes to the Agenda
This year, attendees can expect notable enhancements driven by feedback from last year's participants. Michael Pearlmutter, CEO of the EveryLife Foundation, highlighted that advocates sought more connection time and opportunities for storytelling refinement. The expanded agenda responds directly to these calls for change, ensuring every voice is heard amid this critical discourse.
- New programming: An additional half-day set for February 24 focuses on crafting personal narratives in dedicated sessions led by community leaders and past award winners.
- Networking opportunities: The Welcome Reception will create intentional spaces for meet-ups among Young Adult Rare Disease Advocates (YARR) members and Community Scholarship recipients.
The Legislative Conference scheduled for February 25 promises a refreshed structure aimed at maximizing attendee engagement. With a gallery showcasing the work of 2025's Rare Artists included, this event promises to blend art with lived experiences within the rare disease realm seamlessly. Traders often overlook such intersections; however, they represent rich narrative potential that fuels advocacy momentum.
Legislative Focus: Making Noise on Capitol Hill
The Senate Special Committee on Aging takes center stage during this week with a hearing set to scrutinize the FDA's role in developing therapies for rare diseases. As if that’s not enough firepower, attendees will have their moment in front of Congress following a briefing from the Rare Disease Congressional Caucus. Expect fervent discussions around regulatory hurdles facing patients needing expedited access to crucial therapies—these dialogues are pivotal in shaping future funding allocations or shifting regulatory landscapes.
The underlying question? Are our legislators truly listening?
The culmination of these activities leads up to presenting the RareVoice Lifetime Achievement Award—a recognition awarded only when one's contributions have tangibly uplifted the rare disease community over decades. This year’s honoree is Frank J. Sasinowski—a heavyweight who has facilitated numerous FDA approvals through his career and shaped how policy interacts with science in real-time.
